|
ZNF790 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.318400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.475200E-01 |
| Normal-vs-Stage2 |
5.282500E-02 |
| Normal-vs-Stage3 |
3.82399999999672E-05 |
| Normal-vs-Stage4 |
2.87350000016673E-07 |
| Stage1-vs-Stage2 |
9.850400E-02 |
| Stage1-vs-Stage3 |
5.50699999999349E-05 |
| Stage1-vs-Stage4 |
5.34570000043644E-07 |
| Stage2-vs-Stage3 |
4.138600E-01 |
| Stage2-vs-Stage4 |
1.270250E-01 |
| Stage3-vs-Stage4 |
2.468800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.042000E-03 |
| Normal-vs-AfricanAmerican |
6.863200E-03 |
| Normal-vs-Asian |
3.132600E-01 |
| Caucasian-vs-AfricanAmerican |
4.745400E-01 |
| Caucasian-vs-Asian |
9.725600E-01 |
| AfricanAmerican-vs-Asian |
7.249400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.477120E-03 |
| Normal-vs-Female |
3.294000E-02 |
| Male-vs-Female |
2.729400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.005170E-01 |
| Normal-vs-Age(41-60Yrs) |
1.538970E-01 |
| Normal-vs-Age(61-80Yrs) |
1.160770E-04 |
| Normal-vs-Age(81-100Yrs) |
3.176200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.858600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.452200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.226800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.135640E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.230960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.503400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.906000E-02 |
| Normal-vs-Grade 2 |
5.280800E-01 |
| Normal-vs-Grade 3 |
1.375270E-04 |
| Normal-vs-Grade 4 |
1.32949999898102E-08 |
| Grade 1-vs-Grade 2 |
1.404550E-01 |
| Grade 1-vs-Grade 3 |
1.859470E-03 |
| Grade 1-vs-Grade 4 |
3.6286000000274E-06 |
| Grade 2-vs-Grade 3 |
5.565300E-04 |
| Grade 2-vs-Grade 4 |
3.74999999941394E-08 |
| Grade 3-vs-Grade 4 |
5.400400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.471800E-01 |
| Normal-vs-ccB subtype |
2.04029999999467E-05 |
| ccA subtype-vs-ccB subtype |
8.77179999969613E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.919300E-03 |
| Normal-vs-N1 |
4.443500E-03 |
| N0-vs-N1 |
2.829800E-01 |
|
|
